Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-628-5 | CAS number: 108-90-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restriction (Only characterization instead of identification of the metabolites. Analytical purity not reported).
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- The pharmacokinetics of inhaled chlorobenzene in the rat
- Author:
- Sullivan, T.M. et al.
- Year:
- 1 983
- Bibliographic source:
- Toxicol. Appl. Pharmacol. 71:194 - 203
- Reference Type:
- secondary source
- Title:
- Environmental toxicology: organic pollutants. Ellis Horwood limited
- Author:
- Fawell J.K., Hunt S. 1988. Environmental toxicology: organic pollutants.
- Year:
- 1 988
- Bibliographic source:
- Ellis Horwood limited.Publishers-Chichester. Halsted Press: a division of John wiley & Sons. New York-Chichester-Brisbane-Toronto
Materials and methods
- Objective of study:
- distribution
- excretion
- metabolism
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- Only characterization instead of identification of the metabolites. Analytical purity not reported
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Chlorobenzene
- EC Number:
- 203-628-5
- EC Name:
- Chlorobenzene
- Cas Number:
- 108-90-7
- Molecular formula:
- C6H5Cl
- IUPAC Name:
- chlorobenzene
- Details on test material:
- - Name of test material (as cited in study report): Chloro[U-14C]benzene
- Analytical purity: no data
- Radiochemical purity (if radiolabelling): 98%
- Specific activity (if radiolabelling): 1.12 µCi/µmol
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- Chloro[U-14C]benzene
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Laboratory Supply Co., Indianapolis, Ind., USA
- Age at study initiation: 58-65 days old
- Weight at study initiation: 160-210 g
- Housing: Roth type metabolism cage after exposure
- Individual metabolism cages: yes
- Diet (e.g. ad libitum): lab chow ad libitum
- Water (e.g. ad libitum): tap water
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMPER DESCRIPTION
- Exposure apparatus: 40-liter glass chromatography jar
- Source and rate of air: [14C]-chlorobenzene vapor was generated by passing a portion of the total air flow though a heated flask containing glass beads. The[14C]-chlorobenzene was infused through a septum immediately upstream from the flask using a gas-tight syringe ans variable speed syringe pump. The vapor passed through a mixing chamber before re-entering the main air flow. Total air flow was 14 liters/min.
- Concentration of test material in vehicle (if applicable): 100 ppm, 400 ppm, and 700 ppm
- Duration and frequency of treatment / exposure:
- 8 hours per day for either 1 day or 5 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Single exposure: 100, 400, 700 ppm. Repeated exposure :400 ppm
- No. of animals per sex per dose / concentration:
- 100, 400, and 700 ppm group for 8 hours: 15 animals
Multiple exposure regimen : 6 animal each group for 5 days
3 animals for the first 4 days of the multiple exposure regimen. 6 rats exposed only the fifth day of every exposure block (single exposure regimen)
12 rats were exposed in a 1-day repeat study at 400 ppm - Control animals:
- no
- Details on study design:
- - Dose selection rationale: the authors intended to examine the dose dependency of parameters indicative of the toxicity process and effect of repeate exposure. Moreover 400 ppm concentration was choosed to account for the statistical validity of the blocking effect.
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled (delete / add / specify): urine, blood, epididymal fat, perinatal fat, kidneys, lungs, liver
- Statistics:
- The design of the treatment procedure allowed only one exposure concentration to be used in any given exposure block. The significance of the blocking factor was estimated in a separate analysis of variance (ANOVA) using the two groups of singly exposed rats exposed to 400 ppm. The magnitude of all other treatment effects was estimated by performing ANOVA on the data from the 100, 700, and the first 400 ppm exposure blocks, excluding the data from the repeated 400 ppm block. Comparison between treatment groups were based on the t statistic.
Results and discussion
- Preliminary studies:
- No significant fecal excretion of chlorobenzene or its metabolites occurs in rats (Williams et al., 1959). Preliminary studies indicated that [14C]-labeled material excreted in the urine and expired air after 48 hr postexposure amounted to no more that 2% of the total excreted from 0 to 48 hr.
Toxicokinetic / pharmacokinetic studies
- Details on distribution in tissues:
- There was no evidence of of accumulation in the rats sacrificed immediately after exposure, except in kidney (single exposure 0hr vs multiple exposure 0 -hr). There was a tendency at the 48 hrs after exposure for mutiply exposed rats to exhibit higher tissue burdens than rats exposed only once. The [14C]chlorobenzene of adipose tissue increased about 8 to 10 fold when the concentration was increased from 100 to 400 ppm and about 3 to 5 fold from 400 to 700 ppm.
Transfer into organs
- Test no.:
- #1
- Transfer type:
- other: inhaltion/lungs/ blood / target organs
- Observation:
- distinct transfer
- Details on excretion:
- 14 [C]-Chlorobenzene and/or metabolites excreted in the urine and expired air are shown in table 1. Significant differences between multiply and singly exposed rats were observed at all the three concentrations and among all three concentations for both exposure regimens. The percentage of material excreted via exhalation increased with increasing exposure concentration and was decreased among multiply exposed rats compared to those singly exposed. There was no effect of exposure regimen in the total micromoles of chlorobenzene equivalents excreted in the urine (see Table 1) . There was a significant difference in the amount of 14 C-chlorobenzene expired between the two 400 ppm, singly exposed groups of rats, with the rats of the repeat study expiring more than rats in the initial group.
Toxicokinetic parametersopen allclose all
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: 0.81 hr. Apparent half-lives of respiratory elimination following 100 ppm single inhalation exposure of rats to 14C-Chlorobenzene. Fast phase
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 2nd: 8.77 hr. Apparent half-lives of respiratory elimination following 100 ppm single inhalation exposure of rats to 14C-Chlorobenzene. Slow phase
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: 0.60 hr. Apparent half-lives of respiratory elimination following 100 ppm single inhalation exposure of rats to 14C-Chlorobenzene. Fast phase
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 2nd: 9.24 hr. Apparent half-lives of respiratory elimination following 100 ppm multiple inhalation exposure of rats to 14C-Chlorobenzene. Slow phase (Data at the 12-, 24-, 36-, and 48- hour sampling times described the terminal portion of the respiratory excr
- Test no.:
- #2
- Toxicokinetic parameters:
- half-life 1st: 1.13 hr. Apparent half-lives of respiratory elimination following 400 ppm single inhalation exposure of rats to 14C-Chlorobenzene. Fast phase ( The more rapid phase of respiratory elimination).
- Test no.:
- #2
- Toxicokinetic parameters:
- half-life 2nd: 7.62 hr . Apparent half-lives of respiratory elimination following 400 ppm single inhalation exposure of rats to[14C-Chlorobenzene. Slow phase
- Test no.:
- #2
- Toxicokinetic parameters:
- half-life 1st: 0.83 hr. Apparent half-lives of respiratory elimination following 400 ppm multiple inhalation exposure of rats to [14C]-chlorobenzene. Fast phase
- Test no.:
- #2
- Toxicokinetic parameters:
- half-life 2nd: 8.56 hr. Apparent half-lives of respiratory elimination following 400 ppm multipleinhalation exposure of rats to [14C]-chlorobenzene. Slow phase
- Test no.:
- #3
- Toxicokinetic parameters:
- half-life 1st: 1.19 hr. Apparent half-lives of respiratory elimination following 400 ppm single inhalation exposure of rats to [14C]-chlorobenzene. Fast phase
- Test no.:
- #3
- Toxicokinetic parameters:
- half-life 3rd: 7.70 hr. Apparent half-lives of respiratory elimination following 400 ppm single inhalation exposure of rats to [14C]-chlorobenzene. Slow phase
- Test no.:
- #4
- Toxicokinetic parameters:
- half-life 1st: 3.65 hr. Apparent half-lives of respiratory elimination following 700 ppm single inhalation exposure of rats to [14C]-chlorobenzene. Fast phase
- Test no.:
- #4
- Toxicokinetic parameters:
- half-life 2nd: 5.73 hr. Apparent half-lives of respiratory elimination following 7400 ppm single inhalation exposure of rats to [14C]-chlorobenzene. Slow phase
- Test no.:
- #4
- Toxicokinetic parameters:
- half-life 1st: 1.62 hr. Apparent half-lives of respiratory elimination following 700 ppm multiple inhalation exposure of rats to [14C]-chlorobenzene. Fast phase
- Test no.:
- #4
- Toxicokinetic parameters:
- half-life 2nd: 6.60 hr. Apparent half-lives of respiratory elimination following 700 ppm multiple inhalation exposure of rats to [14C]-chlorobenzene. Slow phase
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- The metabolite were only characterised and seperated into four categories: 1) the initial category contained metabolites extracted into ether from raw, untreated urine; 2) the G/S category contained residues which had been excreted as glucuronid (G) or sulfate (S) conjugates; 3) mercapturic acid category; 4) unexctracted included all metabolites not extracted from the urine. Differences between singly and multiply exposed groups were not significant.
Any other information on results incl. tables
With regard to metabolites, the 3 concentrations (100, 400, and 700 ppm) resulted in signifcantly different mercapturic acid percentages among the singly exposed groups (p< 0.05). In the multiply exposed groups, the difference between the 400- and the 700 ppm results was not signifcant, although both were significantly decreased from the 100 ppm results. When the exposure concentration was increased from 100 to 700 ppm, the mercapturic acid percentage of the total was reduced by 27 % for the singly exposed group and 24 % for the multiply exposed group.
Table 4 presents the apparent half-lives (t1/2) calculated from regression models obtained by combining all rats in each treatment group. The exposure regimen effect was significant only at the 700 ppm concentration, with multiply exposed rats yielding a shorter fast phase t1/2 than singly exposed rats. There was no signifcant effect of concentration on respiratory elimination between the 100- and 400 ppm groups. However, the fast phase half-lives of the 700 ppm rats were longer than those observed at lower exposure concentrations.
Applicant's summary and conclusion
- Executive summary:
Sullivan et al., 1983
Male Sprague-Dawly rats were exposed for 8 hr/day to 100, 400, or 700 ppm of [14C]-chlorobenzene vapor for either 1 day or 5 days. The study was conducted according to OECD guideline 417 with deviations (Only characterization instead of identification of the metabolites. Analytical purity not reported). 6 rats of each group were exposed for 5 consecutive days (multiple exposure regimen). Another 3 rats were exposed for the first 4 days of the multiple exposure regimen, but were sacrificed after 16 hr their final exposure. The other 6 rats were exposed only on the fifth day on each exposure block (single exposure regimen). Another group of 12 rats was exposed in a 1-day repeated study at 400 ppm to account for the statistical signifcance of blocking effect.
Immediataley after the fifth day of exposure, 6 of the 12 remaining rats (3 singly exposed and 3 multiply exposed) were placed in metabolism cages for collection of urine and expired material. The other 6 rats were sacrificed 48 hr after exposure for assessment of remaining tissue burdens.
There was no evidence of accumulation in the rats sacrificed immediately after exposure, except in kidney (single exposure 0hr vs multiple exposure 0 -hr). There was a tendency at the 48 hrs after exposure, for mutiply exposed rats to exhibit higher tissue burdens than rats exposed only once. The [14C]chlorobenzene of adipose tissue increased about 8 to 10 fold when the concentration was increased from 100 to 400 ppm and about 3 to 5 fold from 400 to 700 ppm.
Respiratory elimination of [14C]chlorobenzene also increased in a dose-dependent way. There are no differences due to dosing regimen in the amount of material excreted in the urine. There was a significant difference in the amount of 14 C-chlorobenzene expired between the two 400 ppm, singly exposed groups of rats, with the rats of the repeat study expiring more than rats in the initial group.
The exposure regimen effect was significant only at the 700 ppm concentration, with multiply exposed rats yielding a shorter fast phase t1/2 than singly exposed rats. There was no signifcant effect of concentration on respiratory elimination between the 100- and 400 ppm groups. However, the fast phase half-lives of the 700 ppm rats were longer than those observed at lower exposure concentrations.
Analysis of treatment effects in the metabolite profile was based on the percentage of mercapturic acid, since this is the paramenter most relavant to toxicity. Differences between singly and multiply exposed groups were not significant. The three concentrations resulted in significantly different mercapturic acid percentages among the singly exposed groups. In the multiply exposed groups, the difference between the 400 ppm and the 700 ppm results was not significant, although were significantly decreased from 100 ppm results. When the exposure concentration was increased from 100 to 700 pppm, the mercapturic acid percentage of the total was reduced by 27 % for singly exposed group and 24% for the multiply exposed group.
The dose-dependent changes are postulated to be due to saturation of the metabolic elimination of chlorobenzene. The effect of multiple exposure is apparently some stimulation of metabolism.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.